112 related articles for article (PubMed ID: 38715125)
1. Overview of clinical, molecular, and therapeutic features of Niemann-Pick disease (types A, B, and C): Focus on therapeutic approaches.
Hosseini K; Fallahi J; Razban V; Sirat RZ; Varasteh M; Tarhriz V
Cell Biochem Funct; 2024 Jun; 42(4):e4028. PubMed ID: 38715125
[TBL] [Abstract][Full Text] [Related]
2. Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: Opportunities for shared therapeutic interventions.
Yañez MJ; Marín T; Balboa E; Klein AD; Alvarez AR; Zanlungo S
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165875. PubMed ID: 32522631
[TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics study with mutation shows that N-terminal domain structural re-orientation in Niemann-Pick type C1 is required for proper alignment of cholesterol transport.
Yoon HJ; Jeong H; Lee HH; Jang S
J Neurochem; 2021 Mar; 156(6):967-978. PubMed ID: 32880929
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Molecular Features of Early Infantile Niemann Pick Type C Disease.
Seker Yilmaz B; Baruteau J; Rahim AA; Gissen P
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709131
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial GSH replenishment as a potential therapeutic approach for Niemann Pick type C disease.
Torres S; Matías N; Baulies A; Nuñez S; Alarcon-Vila C; Martinez L; Nuño N; Fernandez A; Caballeria J; Levade T; Gonzalez-Franquesa A; Garcia-Rovés P; Balboa E; Zanlungo S; Fabrías G; Casas J; Enrich C; Garcia-Ruiz C; Fernández-Checa JC
Redox Biol; 2017 Apr; 11():60-72. PubMed ID: 27888692
[TBL] [Abstract][Full Text] [Related]
6. Pre-mRNA splicing defects and RNA binding protein involvement in Niemann Pick type C disease.
Paron F; Dardis A; Buratti E
J Biotechnol; 2020 Jul; 318():20-30. PubMed ID: 32387451
[TBL] [Abstract][Full Text] [Related]
7. AAV9-NPC1 significantly ameliorates Purkinje cell death and behavioral abnormalities in mouse NPC disease.
Xie C; Gong XM; Luo J; Li BL; Song BL
J Lipid Res; 2017 Mar; 58(3):512-518. PubMed ID: 28053186
[TBL] [Abstract][Full Text] [Related]
8. Targeting defective sphingosine kinase 1 in Niemann-Pick type C disease with an activator mitigates cholesterol accumulation.
Newton J; Palladino END; Weigel C; Maceyka M; Gräler MH; Senkal CE; Enriz RD; Marvanova P; Jampilek J; Lima S; Milstien S; Spiegel S
J Biol Chem; 2020 Jul; 295(27):9121-9133. PubMed ID: 32385114
[TBL] [Abstract][Full Text] [Related]
9. Improvement in lipid and protein trafficking in Niemann-Pick C1 cells by correction of a secondary enzyme defect.
Devlin C; Pipalia NH; Liao X; Schuchman EH; Maxfield FR; Tabas I
Traffic; 2010 May; 11(5):601-15. PubMed ID: 20412078
[TBL] [Abstract][Full Text] [Related]
10. The Genetic Basis, Lung Involvement, and Therapeutic Options in Niemann-Pick Disease: A Comprehensive Review.
Tirelli C; Rondinone O; Italia M; Mira S; Belmonte LA; De Grassi M; Guido G; Maggioni S; Mondoni M; Miozzo MR; Centanni S
Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397448
[TBL] [Abstract][Full Text] [Related]
11. Niemann-Pick C1 functions independently of Niemann-Pick C2 in the initial stage of retrograde transport of membrane-impermeable lysosomal cargo.
Goldman SD; Krise JP
J Biol Chem; 2010 Feb; 285(7):4983-94. PubMed ID: 20007703
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary abnormalities in animal models due to Niemann-Pick type C1 (NPC1) or C2 (NPC2) disease.
Roszell BR; Tao JQ; Yu KJ; Gao L; Huang S; Ning Y; Feinstein SI; Vite CH; Bates SR
PLoS One; 2013; 8(7):e67084. PubMed ID: 23843985
[TBL] [Abstract][Full Text] [Related]
13. Enrichment of NPC1-deficient cells with the lipid LBPA stimulates autophagy, improves lysosomal function, and reduces cholesterol storage.
Ilnytska O; Lai K; Gorshkov K; Schultz ML; Tran BN; Jeziorek M; Kunkel TJ; Azaria RD; McLoughlin HS; Waghalter M; Xu Y; Schlame M; Altan-Bonnet N; Zheng W; Lieberman AP; Dobrowolski R; Storch J
J Biol Chem; 2021 Jul; 297(1):100813. PubMed ID: 34023384
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the sphingomyelin phosphodiesterase 1 gene (SMPD1) in Turkish Niemann-Pick disease patients: mutation profile and description of a novel mutation.
Aykut A; Karaca E; Onay H; Ucar SK; Coker M; Cogulu O; Ozkinay F
Gene; 2013 Sep; 526(2):484-6. PubMed ID: 23618813
[TBL] [Abstract][Full Text] [Related]
15. Laboratory diagnosis of the Niemann-Pick type C disease: an inherited neurodegenerative disorder of cholesterol metabolism.
Sitarska D; Ługowska A
Metab Brain Dis; 2019 Oct; 34(5):1253-1260. PubMed ID: 31197681
[TBL] [Abstract][Full Text] [Related]
16. Niemann-Pick type C disease: molecular mechanisms and potential therapeutic approaches.
Rosenbaum AI; Maxfield FR
J Neurochem; 2011 Mar; 116(5):789-95. PubMed ID: 20807315
[TBL] [Abstract][Full Text] [Related]
17. Niemann-Pick disease type C: analysis of 7 patients.
Xiong H; Bao XH; Zhang YH; Xu YN; Qin J; Shi HP; Wu XR
World J Pediatr; 2012 Feb; 8(1):61-6. PubMed ID: 21633862
[TBL] [Abstract][Full Text] [Related]
18. Subclinical course of adult visceral Niemann-Pick type C1 disease. A rare or underdiagnosed disorder?
Dvorakova L; Sikora J; Hrebicek M; Hulkova H; Bouckova M; Stolnaja L; Elleder M
J Inherit Metab Dis; 2006 Aug; 29(4):591. PubMed ID: 16802107
[TBL] [Abstract][Full Text] [Related]
19. Identification of mutation in NPC2 by exome sequencing results in diagnosis of Niemann-Pick disease type C.
Alavi A; Nafissi S; Shamshiri H; Nejad MM; Elahi E
Mol Genet Metab; 2013; 110(1-2):139-44. PubMed ID: 23791309
[TBL] [Abstract][Full Text] [Related]
20. Impaired Retromer Function in Niemann-Pick Type C Disease Is Dependent on Intracellular Cholesterol Accumulation.
Dominko K; Rastija A; Sobocanec S; Vidatic L; Meglaj S; Lovincic Babic A; Hutter-Paier B; Colombo AV; Lichtenthaler SF; Tahirovic S; Hecimovic S
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
